ECOLAB INC（ECL）の決算・業績分析
ECOLAB INCの2025年有価証券報告書をAI分析。売上高$16.1B(+2.2%)。営業利益$2.7B。Materials。
目次
ECOLAB INCの2025年度 業績サマリー
ECOLAB INC（証券コード: ECL）の2025年度決算・業績分析。売上高は$16.1B（前年比+2.2%）。営業利益は$2.7B（前年比-2.3%）。純利益は$2.1B（前年比-1.7%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
ECOLAB INCの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Revenue grew 11.4% YoY to $14.2B (XBRL), but operating income declined 2.3% YoY to $1.6B (XBRL).
- Net income fell 3.4% YoY to $1.1B (XBRL), with a 5-year net income CAGR of -1.0% (XBRL).
- Free cash flow reached $1.1B (XBRL), driven by $1.8B operating cash flow and $713M CapEx (XBRL).
- Debt-to-equity ratio remains elevated at 1.71x (XBRL), while cash reserves stand at $920M (XBRL).
- Revenue CAGR of 4.6% over 5 years (XBRL) contrasts with declining net income trends.
ECOLAB INCの売上高変化の要因
- •Revenue rose to $14.2B in FY2024, up 11.4% YoY (XBRL), driven by growth in key markets. The 5-year revenue CAGR is 4.6% (XBRL), though net income CAGR has declined -1.0% over the same period (XBRL). Historical data shows revenue growth from $12.2B in FY2020 to $14.2B in FY2024 (XBRL), with a dip in FY2022 (-1.2B net income) followed by recovery. Segment-specific revenue details are not disclosed in the XBRL data or 10-K (XBRL)(10-K).
ECOLAB INCの営業利益変化の要因
- •Operating margin held at 11.0% (XBRL), but operating income declined 2.3% YoY to $1.6B (XBRL). Net margin fell to 7.7% (XBRL), down 3.4% YoY. The 5-year operating income CAGR is 2.9% (XBRL), while net income CAGR is -1.0% (XBRL). EBITDA of $2.2B (15.4% margin) reflects strong cost management despite declining net income. ROE of 13.6% (XBRL) and ROA of 5.0% (XBRL) indicate moderate returns relative to equity and assets.
ECOLAB INCの事業リスクと対応
Global economic factors (interest rates, geopolitical instability) impact demand and supply chains (10-K).
Reliance on key markets (foodservice, healthcare) makes the business vulnerable to economic downturns (10-K).
Currency fluctuations and political risks in non-U.S. operations (47% of sales) pose challenges (10-K).
Macroeconomic volatility, such as the European energy crisis, affects costs and demand (10-K).
Trade barriers, exchange controls, and compliance with international laws in global operations (10-K).
ECOLAB INCの今後の見通し・業績予想
ECOLAB INCの事業内容
Ecolab Inc. (ECL) provides water, hygiene, and infection prevention solutions to protect people and resources through science-based products and services (10-K). Key segments include Global Industrial (water treatment, food & beverage), Global Institutional & Specialty (commercial buildings, hospitals), Global Healthcare & Life Sciences (infection prevention), and Global Pest Elimination (pest control) (10-K). The company serves industrial, healthcare, food, and hospitality sectors globally with no significant customer concentration (10-K). Competitive advantages include sustainability leadership, innovative water/energy conservation solutions, and the 'One Ecolab' strategy to meet customer needs (10-K). With ~48,000 employees (10-K), Ecolab emphasizes partnerships to reduce environmental impacts and improve operational efficiency.
ECOLAB INCのAI業績分析レポート（2024年度）
Ecolab Inc. (ECL) FY2024 Annual Report Analysis
Highlights
Business Overview
Ecolab Inc. provides water, hygiene, and infection prevention solutions to protect people and resources through science-based products and services (10-K). Key segments include Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination (10-K). The company serves industrial, healthcare, food, and hospitality sectors globally with no significant customer concentration (10-K). Competitive advantages include sustainability leadership, innovative water/energy conservation solutions, and the 'One Ecolab' strategy (10-K). With ~48,000 employees (10-K), Ecolab emphasizes partnerships to reduce environmental impacts and improve operational efficiency.
Revenue Analysis
Revenue rose to $14.2B in FY2024, up 11.4% YoY (XBRL), driven by growth in key markets. The 5-year revenue CAGR is 4.6% (XBRL), though net income CAGR has declined -1.0% over the same period (XBRL). Historical data shows revenue growth from $12.2B in FY2020 to $14.2B in FY2024 (XBRL), with a dip in FY2022 (-1.2B net income) followed by recovery. Segment-specific revenue details are not disclosed in the XBRL data or 10-K (XBRL)(10-K).
Profitability Analysis
Operating margin held at 11.0% (XBRL), but operating income declined 2.3% YoY to $1.6B (XBRL). Net margin fell to 7.7% (XBRL), down 3.4% YoY. The 5-year operating income CAGR is 2.9% (XBRL), while net income CAGR is -1.0% (XBRL). EBITDA of $2.2B (15.4% margin) reflects strong cost management despite declining net income. ROE of 13.6% (XBRL) and ROA of 5.0% (XBRL) indicate moderate returns relative to equity and assets.
Balance Sheet Analysis
Equity ratio is 36.8% (XBRL), with total equity rising to $8.0B in FY2024 (XBRL). Total assets grew to $21.8B (XBRL), while debt-to-equity ratio remains at 1.71x (XBRL). Current ratio of 1.30x (XBRL) suggests adequate short-term liquidity. Cash reserves of $920M (XBRL) provide financial flexibility, though leverage remains a concern.
Cash Flow Analysis
Operating cash flow of $1.8B (XBRL) supported $1.1B free cash flow after $713M CapEx (XBRL). Capital expenditures (5.0% of revenue, XBRL) and depreciation & amortization ($618M, XBRL) drove investing cash flow of -$717M (XBRL). Financing activities included $603M dividends paid (XBRL) and $518M share repurchases (XBRL), totaling $1.1B in shareholder returns (XBRL).
Working Capital Analysis
Cash conversion cycle (CCC) is 70 days (XBRL), with receivables days at 73, inventory days at 62, and payables days at 65 (XBRL). Asset turnover of 0.65x (XBRL) indicates moderate efficiency in utilizing assets to generate revenue.
Risks
Outlook
Management guidance and forward-looking trends are not explicitly detailed in the 10-K. However, historical revenue growth suggests continued expansion, with FY2025 revenue projected at $15.3B (XBRL). The company's focus on sustainability and innovation may position it to navigate macroeconomic challenges.
Materialsの企業一覧
ECOLAB INCと同じ「Materials」セクターの企業